Investing.com - Financial Markets Worldwide

Shineco creates digital division to combine cell assets with blockchain

AuthorVlad Schepkov
Published 13/08/2025, 11:34
SISI
-9.98%

Shineco Inc. (SISI) announced the establishment of a Biological Cell Digital Business Division and appointed Lin Hongguang as general manager to integrate the company’s biological cell assets with blockchain technology.

The Beijing-based induced pluripotent stem cell technology platform manufacturer stated the division aims to build a blockchain-based ecosystem for managing biological cell assets. The division’s objectives include promoting standardized management of biological cell assets, establishing an induced pluripotent stem cells cell bank, and creating compliance frameworks for asset traceability and security confirmation.

The division plans to develop blockchain tools including equity transfer mechanisms to address circulation inefficiencies in cell assets. The company stated this initiative is intended to allow medical and research institutions more flexible resource allocation and lower service access barriers through flexible payment methods.

Lin Hongguang previously served as chief researcher at the Korea Digital Currency Research Institute and has experience in blockchain and digital asset industries. His responsibilities include developing standards for on-chain cell asset listings, expanding global ecosystem collaborations, and establishing a global distribution network for biological cell products.

"Bio-cell technology is a core driving force of the ’big health’ industry, but the industry currently faces challenges such as low global circulation efficiency, difficulty in cross-regional collaboration, and high user service thresholds," said Jennifer Zhan, CEO of Shineco. "We established the Biological Cell Digital Division precisely to break through these bottlenecks through a cell asset chain model."

Shineco’s core business encompasses induced pluripotent stem cell technology platforms and extracellular vesicle-derived products. The company provides health and medical products and services focused on healthy living and quality of life improvement.

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.